Company / Accounts Receivable
GoodRx Holdings, Inc. Accounts Receivable History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$235.7M
FY2025
5-year range
$117.1M / $235.7M
FY2021-FY2025
Trend
+61.5%
vs FY2024
Sector context
#145 of 288
Information Technology
What the data says
At $236M, GoodRx Holdings, Inc.'s accounts receivable ranks #145 of 288 in the Information Technology sector. Accounts Receivable has increased for 3 consecutive years, from $117M in FY2022 to $236M in FY2025.
Based on SEC 10-K filings.
$236M in FY2025 with a 5-year CAGR of +28.0%.
Improved from $144M to $236M over the past 2 years.
Information Technology sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- +28.0%
- 10-Year CAGR
- -
Sector benchmark
#145 of 288 in Information TechnologyTop 50% of 288This company $235.7M Sector average $1.5B
▼
-83.9% below sector average
Key checks
Key Insights
- GoodRx Holdings, Inc.'s accounts receivable has grown for 3 consecutive years.
- 5-year CAGR of +28.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 61.5% year-over-year.
- Ranks #145 out of 288 companies in the Information Technology sector.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $235.7M | +61.5% |
| FY2024 | $145.9M | +1.6% |
| FY2023 | $143.6M | +22.6% |
| FY2022 | $117.1M | -0.8% |
| FY2021 | $118.1M | +71.8% |
| FY2020 | $68.7M | +42.8% |
| FY2019 | $48.1M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026